[期刊]
  • 《Clinical and experimental nephrology》 2020年24卷Suppl.1期

摘要 : Background Dotinurad is a novel, selective urate reabsorption inhibitor, which reduces serum uric acid levels by selective inhibition of the urate transporter 1. We evaluated the efficacy and safety of dotinurad versus febuxostat,... 展开

相关作者
相关关键词